$Ventyx Biosciences(VTYX.US)$$蔚来(NIO.US)$$礼来(LLY.US)$$硕迪生物(GPCR.US)$ Obesity Drug - Update & Battle for Skinny SubQ- $VKTX ph2 results puts the company in driver's seat after showing impressive results both in efficacy and safety $VKTX has shown twice as much weight loss in 13 weeks what $LLY has done in 12 weeks and what $NVO has shown in 40 plus weeks In safety, VKTX shown its superiority too vs LLY and NVO For comparison...
$Viking Therapeutics(VKTX.US)$$礼来(LLY.US)$$诺和诺德(NVO.US)$$安进(AMGN.US)$$硕迪生物(GPCR.US)$ Demand is too high for the obesity drugs but major drug companies unable to keep up with this demand. This will be an opportunity for multiple drug companies to take a pie out of the obesity market. SubQ likely to be prescribed first for short term weight loss and oral drugs for maintenance. This is not an oncology space ...
Leerink's David Risinger cheered the positive safety and efficacy results in obese patients, but market reaction tainted Structure's acquisition prospects.
Despite its rising cash burn rate, Structure Therapeutics remains in a secure financial state due to its focus on cash runway and low burn to market cap ratio. The company's strong cash runway and fund-raising potential mitigate concerns about its cash burn situation.
The increasing demand for GLP-1 weight-loss medications indicates that in the next ten years, a significant number of Americans may lose hundreds of millions of pounds collectively. This shift in weight could cause a redistribution of trillions of dollars. Last week,$诺和诺德(NVO.US)$presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
1.The global market space for weight-loss drugs exceeds 100 billion dollars. Wegovy, which has sparked discussions on social media, is a GLP-1 receptor agonist medication. GLP-1 drugs have now become a goldmine for pharmaceutical giants Novo Nordisk and Eli Lilly, propelling Novo Nordisk to become the most valuable company in Europe, surpassing LVMH Group. It is said that by sticking to a weekly injection, weight can be...
Is the diet pill craze influencing the eating habits of Americans? Elon Musk stated on social media platform X that the weight loss drug Ozempic has actually had a shocking impact on food sales at Walmart. On Friday, October 6th, while most sectors on the S&P 500 saw a decline of only 0.5% in essential consumer goods from the previous day, major retailers experienced significant drops. Walmart fell by ...
Talented Mr Ripley :
LOL! that is a far fetched theory. the true reason for the aforementioned decreases in food consumption is that emergency EBT Food Stamp Benefits and stimulus monies have stopped - no more free money.
Join✅DiscordTalented Mr Ripley:
That is also, a far fetched theory. It’s actually because of rising grain, sugar, & corn prices as well as the interest rate hikes making food much more expensive, meaning people are more careful about how they spend.
Talented Mr RipleyJoin✅Discord:
fast food/dining out sales are up. people don't have time to and/or prefer not to cook, so they order take-out. food delivery sales are up, even if the stocks are down.
Join✅DiscordTalented Mr Ripley:
Yes for a lot of big names. but their margins are way down due to the climbing rates & food costs. Net Profit is way down for a lot of food distributors YOY, even if revenue is growing. I’m buying the hell out of food distributors and restaurants currently, Pepsi $百事可乐 (PEP.US)$ being my main focus. People are never going to stop buying food, especially sugary sh!t
$Avalo Therapeutics(AVTX.US)$ Poor Performance So Far Over the past few weeks, we have seen a lot of unusual activity in this ticker symbol. If there is anyone out there who knows why activity has picked up in AVTX, then please enlighten me. Over the past few years, putting money into this company has been losing bet. Any stock that is in a long-term downtrend is usually something that I would stay away from. Intriguing Technical Developmemts Over the past few weeks,...
硕迪生物股票讨论区
Obesity Drug - Update & Battle for Skinny
SubQ- $VKTX ph2 results puts the company in driver's seat after showing impressive results both in efficacy and safety
$VKTX has shown twice as much weight loss in 13 weeks what $LLY has done in 12 weeks and what $NVO has shown in 40 plus weeks
In safety, VKTX shown its superiority too vs LLY and NVO
For comparison...
Demand is too high for the obesity drugs but major drug companies unable to keep up with this demand. This will be an opportunity for multiple drug companies to take a pie out of the obesity market.
SubQ likely to be prescribed first for short term weight loss and oral drugs for maintenance. This is not an oncology space ...
This stock seems to be looked past but these analysis have HIGH expectations. I think ill be entering soon. NFA
Last week, $诺和诺德(NVO.US)$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
Wegovy, which has sparked discussions on social media, is a GLP-1 receptor agonist medication. GLP-1 drugs have now become a goldmine for pharmaceutical giants Novo Nordisk and Eli Lilly, propelling Novo Nordisk to become the most valuable company in Europe, surpassing LVMH Group.
It is said that by sticking to a weekly injection, weight can be...
Elon Musk stated on social media platform X that the weight loss drug Ozempic has actually had a shocking impact on food sales at Walmart.
On Friday, October 6th, while most sectors on the S&P 500 saw a decline of only 0.5% in essential consumer goods from the previous day, major retailers experienced significant drops. Walmart fell by ...
$礼来(LLY.US)$ $诺和诺德(NVO.US)$ $安进(AMGN.US)$ $硕迪生物(GPCR.US)$ $亚马逊(AMZN.US)$ $SPDR 标普500指数ETF(SPY.US)$
Poor Performance So Far
Over the past few weeks, we have seen a lot of unusual activity in this ticker symbol. If there is anyone out there who knows why activity has picked up in AVTX, then please enlighten me.
Over the past few years, putting money into this company has been losing bet. Any stock that is in a long-term downtrend is usually something that I would stay away from.
Intriguing Technical Developmemts
Over the past few weeks,...
暂无评论